Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment

被引：0
|
作者：
Paulo Roberto Barbosa Evora
机构：
[1] University of São Paulo,Department of Surgery and Anatomy (Division of Cardiothoracic Surgery); Ribeirão Preto School of Medicine
来源：
Critical Care | / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Inhibition of fibrosis and inflammation by a soluble guanylate cyclase stimulator in models of liver disease
    Hall, Katherine
    Jacobson, Sarah
    Zhang, Ping
    Liu, Guang
    Sarno, Renee
    Catanzano, Victoria
    Bernier, Sylvie
    Currie, Mark
    Masferrer, Jaime
    [J]. HEPATOLOGY, 2017, 66 : 1073A - 1074A
  • [32] Soluble guanylate cyclase and cGMP-dependent protein kinase I expression in the human corpus cavernosum
    T Klotz
    W Bloch
    J Zimmermann
    P Ruth
    U Engelmann
    K Addicks
    [J]. International Journal of Impotence Research, 2000, 12 : 157 - 164
  • [33] Enhancing Soluble Guanylate Cyclase Activity To Modulate No/cgmp Signaling In Immature Human Airway Smooth Muscle
    Thompson, M.
    Thu, J.
    Karass, M.
    Pandya, H.
    Martin, R. J.
    Pabelick, C.
    Prakash, Y. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [34] Membrane guanylate cyclase, a multimodal transduction machine: history, present, and future directions
    Sharma, Rameshwar K.
    Duda, Teresa
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2014, 7
  • [35] Soluble guanylate cyclase and cGMP-dependent protein kinase I expression in the human corpus cavernosum
    Klotz, T
    Bloch, W
    Zimmermann, J
    Ruth, P
    Engelmann, U
    Addicks, K
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2000, 12 (03) : 157 - 164
  • [36] Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
    Marton I Siklos
    Ronak P Gandhi
    Rui Xiong
    Isaac T Schiefer
    Vladislav Litosh
    Lawren VandeVrede
    Gregory RJ Thatcher
    [J]. BMC Pharmacology and Toxicology, 14 (Suppl 1)
  • [37] Soluble guanylate cyclase (sGC) stimulators as an emerging treatment for cardiopulmonary disease
    Follmann, Markus
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [38] A novel approach for the treatment of hypertension with the soluble guanylate cyclase stimulating drug
    Chrysant, Steven G.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 635 - 640
  • [39] Is there a new treatment for hypertensive disease in the horizon? Role of soluble guanylate cyclase
    Franco, Veronica
    Oparil, Suzanne
    [J]. HYPERTENSION, 2006, 48 (05) : 822 - 823
  • [40] Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
    Belik, Jaques
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 971 - 979
12345